Stock Chart
PTCT
Type: SELL growth_1yr
Strike: $70
Premium: $19.30
Expiry: Jan 15, 2027
Target: $66
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About PTCT - PTC Therapeutics, Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating …
Key Statistics
More PTCT Analysis
This PTCT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PTCT's price movements with trendlines, gamma walls, and key support/resistance levels.